Literature DB >> 23055013

Changes in ghrelin and asymmetrical dimethylarginine in obese Mexican adolescents after six-month lifestyle intervention.

Fengyang Huang1, Blanca Estela del-Río-Navarro, José Alfredo Pérez Ontiveros, Eliseo Ruiz-Bedolla, Efraín Navarro-Olivos, Santiago Villafaña, Guadalupe Bravo, Enrique Hong.   

Abstract

The aim of this study was to evaluate the effect of a six-month lifestyle intervention on ghrelin and asymmetrical dimethylarginine (ADMA) in obese Mexican adolescents. A total of 65 obese Mexican adolescents aged 10-16 years completed a six-month lifestyle intervention. Anthropometric and biochemical parameters were assessed at baseline and at six months. Twenty normal-weight adolescents were also evaluated at baseline. Insulin resistance (IR) was determined by the homeostasis model assessment of IR (HOMA-IR). Ghrelin and ADMA were determined by enzyme-linked immunosorbent assay. Obese adolescents presented significantly higher triglycerides, cholesterol, glucose, insulin, HOMA-IR, and ADMA levels, while ghrelin was significantly lower. The lifestyle intervention led to a significant improvement in HOMA-IR, ghrelin, and ADMA in the whole studied obese subjects. ADMA and ghrelin levels were associated with BMI and IR components. According to the value of HOMA-IR, the obese subjects were divided into subjects with or without IR, no difference in ghrelin and ADMA was observed in these two subgroups. After intervention, the obese with IR showed increased ghrelin and decreased ADMA, while the obese without IR only showed improvement in ghrelin. The multiple linear regression analysis revealed that the changes of systolic blood pressure were the only predictor for the changes of ghrelin in the obese with IR. Our study demonstrated the increase of ADMA and the decrease of ghrelin in obese adolescents. Lifestyle intervention improved insulin resistance, decreased ADMA, and increased ghrelin in obese subjects with IR although no significant weight loss was observed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055013     DOI: 10.1007/s12020-012-9808-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  42 in total

1.  Nitric oxide activity in childhood hypertension.

Authors:  C D Goonasekera; V Shah; D D Rees; M J Dillon
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

2.  Hemodynamic and hormonal effects of human ghrelin in healthy volunteers.

Authors:  N Nagaya; M Kojima; M Uematsu; M Yamagishi; H Hosoda; H Oya; Y Hayashi; K Kangawa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-05       Impact factor: 3.619

3.  Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese Spanish children and adolescents.

Authors:  M P Bahíllo-Curieses; F Hermoso-López; M J Martínez-Sopena; P Cobreros-García; P García-Saseta; M Tríguez-García; J M Marugán-Miguelsanz
Journal:  Endocrine       Date:  2011-10-01       Impact factor: 3.633

4.  Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.

Authors:  Tomomi Shiiya; Masamitsu Nakazato; Masanari Mizuta; Yukari Date; Muhtashan S Mondal; Muneki Tanaka; Shin-Ichi Nozoe; Hiroshi Hosoda; Kenji Kangawa; Shigeru Matsukura
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation.

Authors:  Leandro Soriano-Guillén; Vicente Barrios; Angel Campos-Barros; Jesús Argente
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

7.  Asymmetric dimethylarginine (ADMA) is tightly correlated with growth in juveniles without correlations to obesity related disorders.

Authors:  H-J Gruber; C Mayer; A Meinitzer; G Almer; R Horejsi; R Möller; S Pilz; W März; R Gasser; M Truschnig-Wilders; H Mangge
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-04-01       Impact factor: 2.949

8.  Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome.

Authors:  Rocco Barazzoni; Michela Zanetti; Clara Ferreira; Pierandrea Vinci; Alessia Pirulli; Mariapia Mucci; Franca Dore; Maurizio Fonda; Beniamino Ciocchi; Luigi Cattin; Gianfranco Guarnieri
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

9.  Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women.

Authors:  H J Leidy; J K Gardner; B R Frye; M L Snook; M K Schuchert; E L Richard; N I Williams
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  [The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children].

Authors:  B García Cuartero; C García Lacalle; C Jiménez Lobo; A González Vergaz; C Calvo Rey; M J Alcázar Villar; E Díaz Martínez
Journal:  An Pediatr (Barc)       Date:  2007-05       Impact factor: 1.500

View more
  2 in total

1.  Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin.

Authors:  Emre Avci; Alpaslan Karabulut; Avci Gulcin Alp; Burcu Baba; Cumhur Bilgi
Journal:  J Med Biochem       Date:  2020-10-02       Impact factor: 3.402

2.  Interventions to Treat Obesity in Mexican Children and Adolescents: Systematic Review and Meta-Analysis.

Authors:  Magaly Aceves-Martins; Lizet López-Cruz; Marcela García-Botello; Yareni Yunuen Gutierrez-Gómez; Carlos Francisco Moreno-García
Journal:  Nutr Rev       Date:  2022-02-10       Impact factor: 7.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.